3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Multiple Myeloma
8
Lymphoma, Non-Hodgkin
7
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms, Plasma Cell
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hodgkin Disease
3
Glioma
3
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Melanoma
2
Leukemia
2
Immunoglobulin Light-chain Amyloidosis
2
Glioblastoma
2
Wilms Tumor
1
Solid Tumor
1
Sarcoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Biphenotypic, Acute
1
Fallopian Tube Neoplasms
1
Interventions
Carboplatin
75
Paclitaxel
68
Bevacizumab
44
Taxes
22
Cyclophosphamide
21
pembrolizumab
19
Gemcitabine
19
Cisplatin
18
Topotecan
17
Hyperthermic Intraperitoneal Chemotherapy
14
olaparib
13
liposomal doxorubicin
13
Immunoglobulin G
13
Disulfides
13
Specimen Handling
11
Drug Therapy
11
niraparib
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
sargramostim
7
Surveys and Questionnaires
7
Doxorubicin
7
Docetaxel
7
durvalumab
6
Platinum
6
Nivolumab
6
Letrozole
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fallopian Tube Neoplasms
×
Blood Component Removal
×
Clear all
NCT05920798
2026-04-06
FRAPPE
Mayo Clinic
Phase 1/2
Recruiting
40 enrolled